|Bid||44.38 x 600|
|Ask||48.96 x 800|
|Day's Range||46.53 - 46.81|
|52 Week Range||39.35 - 47.58|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.33%|
IMF lowers U.S. growth outlook to 2.1% for this year and for 2018.
GlaxoSmithKline (GSK) reported a 19.0% rise in 1Q17 revenues to ~7.4 billion pounds, driven by an operational rise of 5.0% and a favorable currency impact of 14.0%.
Thanks to Trump, most investors have been focused on the domestic equity world. But with the possible unwinding of the Trump Trade, foreign stocks have been outperforming as of late and could be interesting additions for some investors out there. Find out if the trends can continue and what the current pitfalls are for international stocks in this week's podcast!